News

One in twenty high-risk cancer patients face the possibility of developing heart failure from certain cancer therapies. Results of a clinical trial point to the benefit of using a more sensitive test to detect heart function issues early, so cancer patients don't have to fight heart failure too.

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again. Using sugar-loving snails as models, researchers have suggested these bad experiences could be causing a switch in our brains, which impacts our future eating habits.

A team of researchers analyzed sequences of ACE2 and other human proteins involved in SARS-CoV-2 infection, such as a class of proteins called integrins.

Pigs will probably never be able to fly, but new research is revealing that some may possess a remarkable level of behavioral and mental flexibility. A new study has tested the ability of four pigs to play a simple joystick-enabled video game.

An early clinical trial has shown that a simple injection of a common antiseptic could boost the effectiveness of radiotherapy for breast cancer and other cancers. Scientists found that a solution of hydrogen peroxide, an antiseptic that cleans cuts and scrapes, can also make cancer cells more sensitive to radiotherapy.

Machine learning study initiated at the Wyss Institute in collaboration with Google Research enables unprecedented AAV capsid diversification with potential for improving gene therapies.

Melatonin administration proved to be an independent prognostic factor and reduced the risk of death of prostate cancer patients in a retrospective study of 955 patients.

Breastfeeding women with COVID-19 do not pass along the SARS-CoV-2 virus in their milk but do transfer milk-borne antibodies that are able to neutralize the virus, researchers report.

Bone marrow transplant can be a lifesaving procedure for patients with blood cancers. However, graft-versus-host disease (GVHD) is a potentially fatal side effect of transplantation, and it has limited treatment options. The severity of GVHD may be reduced by a single strain of bacteria.

Scientists have identified a pathway that all filoviruses, including Ebola, use to gain entry into our cells and shown how they can be stopped in their tracks by at least one FDA-approved drug.